Follow
Ross Dunlap
Ross Dunlap
CEO, Ceres Nanosciences, Inc.
Verified email at ceresnano.com - Homepage
Title
Cited by
Cited by
Year
Application of Nanotrap technology for high sensitivity measurement of urinary outer surface protein A carboxyl-terminus domain in early stage Lyme borreliosis
R Magni, BH Espina, K Shah, B Lepene, C Mayuga, TA Douglas, ...
Journal of translational medicine 13 (1), 346, 2015
702015
Nanotrap® particles improve detection of SARS-CoV-2 for pooled sample methods, extraction-free saliva methods, and extraction-free medium methods
RA Barclay, I Akhrymuk, A Patnaik, V Callahan, C Lehman, P Andersen, ...
BioRxiv, 2020
52020
The system can't perform the operation now. Try again later.
Articles 1–2